Amsparity
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amsparity, covering 2025-10-22 to 2025-10-22. Get the full timeline:
Most recent: EMA Authorised: Amsparity (adalimumab) — Pfizer Europe MA EEIG
1 regulatory and trial event tracked for Amsparity, covering 2025-10-22 to 2025-10-22. Get the full timeline:
Most recent: EMA Authorised: Amsparity (adalimumab) — Pfizer Europe MA EEIG